Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-18 | 2020-10-22 | 118247 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-01 | 2020-10-30 | 125467 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-27 | 2021-11-11 | 144755 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-09 | 2021-12-08 | 145446 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-16 | 2021-11-11 | 145791 |
| TEVA-MORPHINE SR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-05-12 | 2022-10-29 | 160448 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-01 | 2023-02-09 | 176854 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-22 | 2023-02-09 | 179303 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-08 | 2023-06-27 | 194125 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-06-21 | 195210 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-04 | 2023-08-04 | 197169 |
| TEVA-MORPHINE SR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-11-08 | 2025-02-13 | 242364 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-05-22 | 2025-08-08 | 258127 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2017-04-03 | 2017-10-10 | 5216 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2020-11-19 | 2021-03-04 | 128603 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Actual shortage | 2023-06-08 | 2024-04-11 | 194157 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195847 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2019-10-17 | 2020-06-26 | 96727 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2019-11-28 | 2019-12-06 | 99947 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-03 | 107949 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RASAGILINE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258753 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258473 |
| TEVA-RISPERIDONE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258673 |
| TEVA-RISPERIDONE | 2MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258679 |
| TEVA-RISPERIDONE | 3MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258685 |
| TEVA-RISPERIDONE | 4MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258688 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258711 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258765 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258486 |
| TEVA-SUCRALFATE | 1G | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266359 |
| TEVA-TECNAL | 50MG 330MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258471 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258478 |
| TEVA-TECNAL C 1/2 | 50MG 330MG 30MG 40MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258462 |